Healthcare Of Ontario Pension Plan Trust Fund Atara Biotherapeutics, Inc. Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$29 Billion
Q1 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.5 - $3.04 $181,500 - $367,840	121,000 New	121,000 $194,000
Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $593,085 - $1.08 Million	208,100 New	208,100 $682,000
Q2 2022 Aug 11, 2022	BUY	$4.69 - $9.84 $2.89 Million - $6.07 Million	616,900 New	616,900 $4.81 Million
Q3 2021 Nov 10, 2021	SELL	$11.99 - $17.9 $1.98 Million - $2.95 Million	-165,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$12.89 - $16.58 $3.69 Million - $4.75 Million	-286,500 Reduced 63.46%	165,000 $2.57 Million

Q1 2021 May 13, 2021	SELL	$14.0 - $20.72 $1.51 Million - $2.24 Million	-108,200 Reduced 19.33%	451,500 $6.48 Million
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $4.71 Million - $9.75 Million	371,700 Added 197.71%	559,700 $11 Million
Q3 2020 Nov 12, 2020	BUY	$11.92 - $15.87 $2.24 Million - $2.98 Million	188,000 New	188,000 $2.44 Million
Q2 2020 Aug 11, 2020	SELL	$7.53 - $14.93 $567,460 - $1.13 Million	-75,360 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$5.69 - $17.78 $428,798 - $1.34 Million	75,360 New	75,360 $641,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account